Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Weight control, endocrine hormones and cancer prevention.

King B, Jiang Y, Su X, Xu J, Xie L, Standard J, Wang W.

Exp Biol Med (Maywood). 2013 May;238(5):502-8. doi: 10.1177/1535370213480695. Review.

PMID:
23856901
2.

Energy balance, physical activity, and cancer risk.

Fair AM, Montgomery K.

Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Review.

PMID:
19107429
3.

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.

Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, Perkins SN.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):659-69. doi: 10.1016/j.beem.2008.08.009. Review.

PMID:
18971125
4.
5.

Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.

Nogueira LM, Lavigne JA, Chandramouli GV, Lui H, Barrett JC, Hursting SD.

Cancer Med. 2012 Oct;1(2):275-88. doi: 10.1002/cam4.23. Epub 2012 Aug 6.

6.

Obesity, energy balance, and cancer: new opportunities for prevention.

Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA.

Cancer Prev Res (Phila). 2012 Nov;5(11):1260-72. doi: 10.1158/1940-6207.CAPR-12-0140. Epub 2012 Oct 3. Review.

7.

Obesity and gastric cancer.

Li Q, Zhang J, Zhou Y, Qiao L.

Front Biosci (Landmark Ed). 2012 Jun 1;17:2383-90. Review.

PMID:
22652786
8.

Weight control and cancer preventive mechanisms: role of insulin growth factor-1-mediated signaling pathways.

Xie L, Wang W.

Exp Biol Med (Maywood). 2013 Feb;238(2):127-32. doi: 10.1177/1535370213477602. Review.

9.

Adiponectin: a link between obesity and cancer.

Barb D, Pazaitou-Panayiotou K, Mantzoros CS.

Expert Opin Investig Drugs. 2006 Aug;15(8):917-31. Review.

PMID:
16859394
10.

Administration of physiologic levels of triiodothyronine increases leptin expression in calorie-restricted obese rats, but does not influence weight loss.

Luvizotto RA, Conde SJ, Síbio MT, Nascimento AF, Lima-Leopoldo AP, Leopoldo AS, Padovani CR, Cicogna AC, Nogueira CR.

Metabolism. 2010 Jan;59(1):1-6. doi: 10.1016/j.metabol.2009.06.017. Epub 2009 Oct 28.

PMID:
19846169
11.

Molecular pathways: adiponectin and leptin signaling in cancer.

Vansaun MN.

Clin Cancer Res. 2013 Apr 15;19(8):1926-32. doi: 10.1158/1078-0432.CCR-12-0930. Epub 2013 Jan 25. Review.

12.

Energy restriction and the prevention of breast cancer.

Harvie M, Howell A.

Proc Nutr Soc. 2012 May;71(2):263-75. doi: 10.1017/S0029665112000195. Epub 2012 Mar 14. Review. Erratum in: Proc Nutr Soc. 2012 Aug;71(3):433.

PMID:
22414375
13.

Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies.

Murthy NS, Mukherjee S, Ray G, Ray A.

J Postgrad Med. 2009 Jan-Mar;55(1):45-54. Review.

14.

Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.

Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.

Obesity (Silver Spring). 2008 Jul;16(7):1516-21. doi: 10.1038/oby.2008.249. Epub 2008 May 8.

15.

Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations.

Lejeune MP, Hukshorn CJ, Saris WH, Westerterp-Plantenga MS.

Physiol Behav. 2007 Jun 8;91(2-3):274-80. Epub 2007 Mar 15.

PMID:
17434547
16.

Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells.

Lautenbach A, Budde A, Wrann CD, Teichmann B, Vieten G, Karl T, Nave H.

Nutr Cancer. 2009;61(4):484-91. doi: 10.1080/01635580802610115.

PMID:
19838920
17.

Pediatric obesity. An overview of etiology and treatment.

Schonfeld-Warden N, Warden CH.

Pediatr Clin North Am. 1997 Apr;44(2):339-61. Review.

PMID:
9130924
18.

Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin.

Drew JE.

Proc Nutr Soc. 2012 Feb;71(1):175-80. doi: 10.1017/S0029665111003259. Epub 2011 Oct 21. Review.

PMID:
22014041
19.

[Adiponectin: an anti-carcinogenic adipokine?].

Fève B.

Ann Endocrinol (Paris). 2013 May;74(2):102-5. doi: 10.1016/j.ando.2013.02.005. Epub 2013 Apr 6. Review. French.

PMID:
23570813
Items per page

Supplemental Content

Write to the Help Desk